(RTTNews) - While reporting financial results for the third quarter on Friday, biopharmaceutical company AbbVie, Inc. (ABBV) raised its adjusted earnings guidance for the full-year 2026, based on strong outlook and significant momentum.
We show the main point publicly. Create a free account to continue reading the full article, save it, discuss it, and connect it with market and OSINT context.